SAFETY AND EFFICACY OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR PRODUCED BY RECOMBINANT DNA TECHNOLOGY

被引：10

作者：

SOBEL, BE

机构：

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 1987年 / 10卷 / 05期

关键词：

D O I：

10.1016/S0735-1097(87)80427-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：B40 / B44

页数：5

共 23 条

[1]

BERGMANN SR, 1983, SCIENCE, V220, P1181

[2] ANNOUNCEMENT OF PROTOCOL CHANGE IN THROMBOLYSIS IN MYOCARDIAL-INFARCTION TRIAL [J].

BRAUNWALD, E ;

KNATTERUD, GL ;

PASSAMANI, ER ;

ROBERTSON, TL .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (02) :467-467

[3] THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) TRIAL, PHASE-I - A COMPARISON BETWEEN INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR AND INTRAVENOUS STREPTOKINASE - CLINICAL FINDINGS THROUGH HOSPITAL DISCHARGE [J].

CHESEBRO, JH ;

KNATTERUD, G ;

ROBERTS, R ;

BORER, J ;

COHEN, LS ;

DALEN, J ;

DODGE, HT ;

FRANCIS, CK ;

HILLIS, D ;

LUDBROOK, P ;

MARKIS, JE ;

MUELLER, H ;

PASSAMANI, ER ;

POWERS, ER ;

RAO, AK ;

ROBERTSON, T ;

ROSS, A ;

RYAN, TJ ;

SOBEL, BE ;

WILLERSON, J ;

WILLIAMS, DO ;

ZARET, BL ;

BRAUNWALD, E .

CIRCULATION, 1987, 76 (01) :142-154

[4] ANALYSIS OF COAGULATION AND FIBRINOLYSIS DURING INTRAVENOUS-INFUSION OF RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION [J].

COLLEN, D ;

BOUNAMEAUX, H ;

DECOCK, F ;

LIJNEN, HR ;

VERSTRAETE, M .

CIRCULATION, 1986, 73 (03) :511-517

[5] CORONARY THROMBOLYSIS WITH RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR - A PROSPECTIVE, RANDOMIZED, PLACEBO-CONTROLLED TRIAL [J].

COLLEN, D ;

TOPOL, EJ ;

TIEFENBRUNN, AJ ;

GOLD, HK ;

WEISFELDT, ML ;

SOBEL, BE ;

LEINBACH, RC ;

BRINKER, JA ;

LUDBROOK, PA ;

YASUDA, I ;

BULKLEY, BH ;

ROBISON, AK ;

HUTTER, AM ;

BELL, WR ;

SPADARO, JJ ;

KHAW, BA ;

GROSSBARD, EB .

CIRCULATION, 1984, 70 (06) :1012-1017

[6]

COLLEN D, 1985, THROMBOLYSIS BIOL TH

[7] GENENTECH EXPERIENCE WITH RT-PA (ACTIVASE) [J].

GROSSBARD, EB .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (02) :467-467

[8] HIGH-DOSE INTRAVENOUS STREPTOKINASE FOR ACUTE MYOCARDIAL-INFARCTION - PRELIMINARY-RESULTS OF A MULTICENTER TRIAL [J].

HILLIS, LD ;

BORER, J ;

BRAUNWALD, E ;

CHESEBRO, JH ;

COHEN, LS ;

DALEN, J ;

DODGE, HT ;

FRANCIS, CK ;

KNATTERUD, G ;

LUDBROOK, P ;

MARKIS, JE ;

MUELLER, H ;

DESVIGNENICKENS, P ;

PASSAMANI, ER ;

POWERS, ER ;

RAO, AK ;

ROBERTS, R ;

ROBERTS, WC ;

ROSS, A ;

RYAN, TJ ;

SOBEL, BE ;

WILLIAMS, DO ;

ZARET, BL .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 6 (05) :957-962

[9] THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) COMPARATIVE-STUDIES OF CORONARY REPERFUSION AND SYSTEMIC FIBRINOGENOLYSIS WITH 2 FORMS OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR [J].

MUELLER, HS ;

RAO, AK ;

FORMAN, SA .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 10 (03) :479-490

[10] THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) PHASE-II PILOT-STUDY - TISSUE PLASMINOGEN-ACTIVATOR FOLLOWED BY PERCUTANEOUS TRANS-LUMINAL CORONARY ANGIOPLASTY [J].

PASSAMANI, E ;

HODGES, M ;

HERMAN, M ;

GROSE, R ;

CHAITMAN, B ;

ROGERS, W ;

FORMAN, S ;

TERRIN, M ;

KNATTERUD, G ;

ROBERTSON, T ;

BRAUNWALD, E .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 10 (05) :B51-B64

← 1 2 3 →